Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barnaby Nelson

Showing results (231-240 of 311) with videos related to

Pageof 32
Sort By:
JAMA Psychiatry|November 29, 2016
Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical TrialPatrick D McGorry, Barnaby Nelson, Connie Markulev, et al.
Early Intervention in Psychiatry|July 2, 2023
The self, neuroscience and psychosis study: Testing a neurophenomenological model of the onset of psychosisMarija Krcmar, Cassandra M J Wannan, Suzie Lavoie, et al.
Early Intervention in Psychiatry|June 30, 2021
Cannabidiol for at risk for psychosis youth: A randomized controlled trialG Paul Amminger, Ashleigh Lin, Melissa Kerr, et al.
Schizophrenia Bulletin|February 22, 2020
Emotion Recognition and Adverse Childhood Experiences in Individuals at Clinical High Risk of PsychosisStefania Tognin, Ana Catalan, Gemma Modinos, et al.
Brain : a Journal of Neurology|January 30, 2022
Frontostriatothalamic effective connectivity and dopaminergic function in the psychosis continuumKristina Sabaroedin, Adeel Razi, Sidhant Chopra, et al.
Biological Psychiatry|November 7, 2019
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for PsychosisG Paul Amminger, Barnaby Nelson, Connie Markulev, et al.
Early Intervention in Psychiatry|November 30, 2018
Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocolAmber Weller, John Gleeson, Mario Alvarez-Jimenez, et al.
Psychological Medicine|October 6, 2020
Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosisAna Catalan, Stefania Tognin, Matthew J Kempton, et al.
Schizophrenia (Heidelberg, Germany)|February 20, 2025
Association between Adverse Childhood Experiences and long-term outcomes in people at Clinical High-Risk for PsychosisStefania Tognin, Ana Catalan, Claudia Aymerich, et al.
Psychiatry Research|May 29, 2024
Erythrocyte membrane fatty acid concentrations and myelin integrity in young people at ultra-high risk of psychosisMelissa Collins, Cali Bartholomeusz, Cristina Mei, et al.
Pageof 32

Showing results (231-240 of 311) with videos related to

Sort By:
Pageof 32
JAMA Psychiatry|November 29, 2016
Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical TrialPatrick D McGorry, Barnaby Nelson, Connie Markulev, et al.
Early Intervention in Psychiatry|July 2, 2023
The self, neuroscience and psychosis study: Testing a neurophenomenological model of the onset of psychosisMarija Krcmar, Cassandra M J Wannan, Suzie Lavoie, et al.
Early Intervention in Psychiatry|June 30, 2021
Cannabidiol for at risk for psychosis youth: A randomized controlled trialG Paul Amminger, Ashleigh Lin, Melissa Kerr, et al.
Schizophrenia Bulletin|February 22, 2020
Emotion Recognition and Adverse Childhood Experiences in Individuals at Clinical High Risk of PsychosisStefania Tognin, Ana Catalan, Gemma Modinos, et al.
Brain : a Journal of Neurology|January 30, 2022
Frontostriatothalamic effective connectivity and dopaminergic function in the psychosis continuumKristina Sabaroedin, Adeel Razi, Sidhant Chopra, et al.
Biological Psychiatry|November 7, 2019
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for PsychosisG Paul Amminger, Barnaby Nelson, Connie Markulev, et al.
Early Intervention in Psychiatry|November 30, 2018
Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocolAmber Weller, John Gleeson, Mario Alvarez-Jimenez, et al.
Psychological Medicine|October 6, 2020
Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosisAna Catalan, Stefania Tognin, Matthew J Kempton, et al.
Schizophrenia (Heidelberg, Germany)|February 20, 2025
Association between Adverse Childhood Experiences and long-term outcomes in people at Clinical High-Risk for PsychosisStefania Tognin, Ana Catalan, Claudia Aymerich, et al.
Psychiatry Research|May 29, 2024
Erythrocyte membrane fatty acid concentrations and myelin integrity in young people at ultra-high risk of psychosisMelissa Collins, Cali Bartholomeusz, Cristina Mei, et al.
Pageof 32